Structure-activity relationship studies on N'-aryl carbohydrazide P2X7 antagonists

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Immunology

Background:

• The P2X7 receptor (P2X7R) is a key mediator of inflammation and pain.
• Developing selective P2X7R antagonists is a therapeutic goal for inflammatory diseases and neuropathic pain.

Purpose of the Study:

• To identify and characterize novel N'-aryl acyl hydrazides as P2X7 receptor antagonists.
• To evaluate the in vitro and in vivo efficacy of these compounds in models of inflammation and pain.

Main Methods:

• Structure-activity relationship (SAR) studies were conducted.
• Functional activity was assessed via calcium flux inhibition in cell lines expressing human and rat P2X7 receptors.
• In vitro inhibition of Interleukin-1 beta (IL-1beta) release was measured.
• In vivo efficacy was evaluated in a zymosan-induced peritonitis model and a rat model of neuropathic pain.

Main Results:

• N'-aryl acyl hydrazides were identified as potent P2X7 receptor antagonists.
• Selected compounds demonstrated significant inhibition of IL-1beta release in vitro.
• A representative compound effectively reduced inflammation in the zymosan-induced peritonitis model.
• The compound also attenuated mechanical allodynia in a neuropathic pain model.

Conclusions:

• N'-aryl acyl hydrazides represent a promising class of P2X7 receptor antagonists.
• These compounds exhibit potential for treating inflammatory conditions and neuropathic pain.